Detalhe da pesquisa
1.
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
CA Cancer J Clin
; 73(6): 620-652, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329269
2.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(18): 1672-1684, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870974
3.
Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer.
Curr Opin Oncol
; 35(1): 54-60, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36420570
4.
Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program.
Eur Radiol
; 32(7): 4457-4467, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247089
5.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
N Engl J Med
; 379(24): 2342-2350, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280658
6.
Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis.
Oncologist
; 25(3): e598-e601, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162818
7.
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med
; 377(20): 1919-1929, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28885881
8.
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
BMC Cancer
; 18(1): 598, 2018 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29801465
9.
[Immunotherapy for lung cancer]. / A tüdõrák immunterápiája.
Magy Onkol
; 61(2): 153-157, 2017 Jun 06.
Artigo
em Húngaro
| MEDLINE | ID: mdl-28585617
10.
[Self defense instead of offense - Immunotherapy in lung cancer]. / Támadás helyett önvédelem - Immunterápia tüdõrákban.
Magy Onkol
; 60(1): 28-33, 2016 03 02.
Artigo
em Húngaro
| MEDLINE | ID: mdl-26934348
11.
[Excerpts from the collaborative lung cancer research program of Semmelweis University, the National Institute of Oncology and Korányi Institute of TB and Pulmonology (2010-2015)]. / Szemelvények a Semmelweis Egyetem, az Országos Onkológiai Intézet és az Országos Korányi Tbc és Pulmonológiai Intézet együttmûködésén alapuló tüdõrák-kutatási programból.
Magy Onkol
; 59(4): 282-5, 2015 Dec.
Artigo
em Húngaro
| MEDLINE | ID: mdl-26665187
12.
Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis.
Expert Rev Anticancer Ther
; 23(12): 1305-1313, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850939
13.
Covid-19-fertozés klinikai jelentosége tüdorák és egyéb malignus mellkasi daganatok esetén.
Magy Onkol
; 66(1): 43-49, 2022 Mar 28.
Artigo
em Húngaro
| MEDLINE | ID: mdl-35343974
14.
Underlying reasons for post-mortem diagnosed lung cancer cases - A robust retrospective comparative study from Hungary (HULC study).
Front Oncol
; 12: 1032366, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36505881
15.
Lung cancer in never smokers.
Future Oncol
; 7(10): 1195-211, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21992731
16.
Chromosomal Aberrations in Blood Lymphocytes as Predictors of Respiratory Function After Stereotactic Lung Irradiation.
Front Oncol
; 11: 829972, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35155217
17.
Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary.
Pathol Oncol Res
; 27: 1610041, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35002544
18.
Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016.
Pathol Oncol Res
; 27: 598862, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34257553
19.
Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016.
Pathol Oncol Res
; 27: 603937, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34257563
20.
Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study.
Lung Cancer
; 152: 127-134, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387727